Ramachandran Thazhath Mavali, Rajneesh Aninchent Harayil Rajan, Zacharia George Sarin, Adarsh Rajendran P
Additional Professor, Department of Medical Gastroenterology, Government Medical College, Kozhikode, Kerala, India.
Senior Resident, Department of Medical Gastroenterology, Government Medical College, Kozhikode, Kerala, India.
J Clin Diagn Res. 2017 Sep;11(9):OC01-OC05. doi: 10.7860/JCDR/2017/30705.10529. Epub 2017 Sep 1.
Cirrhosis of the liver and diabetes mellitus are two chronic illnesses with significant impact on the quality of life. Studies from different part of the world have shown the combination to be associated with higher incidence of complications of cirrhosis and reduced survival. However, data on the impact of pre-cirrhotic and post-cirrhotic diabetes on cirrhosis is minimal.
The aim of the study was to determine the complications of cirrhosis patients with and without co-existent DM and to compare the relation between cirrhosis patients with antecedent DM and hepatogenous DM.
The present prospective study was conducted at a tertiary care hospital in Kerala, India, over a period of three years. Cirrhosis patients with and without diabetes, along with subcategorization as antecedent and hepatogenous diabetes, were studied for various complications and outcome including death. Chi-square and Mann-whitney tests were used for comparing data.
Patients with cirrhosis and diabetes had higher incidence of gall stones (27.6% versus 13.2%; p=0.008) and urinary infection (29.3% versus 7.5%; p=<0.001). Incidence of hepatocellular carcinoma and mortality were similar between the groups. Patients with antecedent diabetes and hepatogenous diabetes were similar with respect to complications and mortality. Child-Turcotte-Pugh (CTP) score, Model for End stage Liver Disease (MELD) score, urinary tract and respiratory infections and duration of cirrhosis were independent predictors of mortality in patients with cirrhosis.
Coexistent diabetes mellitus increases the incidence of complications and hospitalizations in cirrhosis patients but without impact on mortality rates. There is no significant morbidity or mortality difference between cirrhotics with antecedent diabetes and hepatogenous diabetes.
肝硬化和糖尿病是两种对生活质量有重大影响的慢性疾病。来自世界不同地区的研究表明,这两种疾病并存与肝硬化并发症发生率升高及生存率降低有关。然而,关于肝硬化前期和肝硬化后期糖尿病对肝硬化影响的数据极少。
本研究旨在确定合并和未合并糖尿病的肝硬化患者的并发症,并比较既往有糖尿病的肝硬化患者和肝源性糖尿病患者之间的关系。
本前瞻性研究在印度喀拉拉邦的一家三级护理医院进行,为期三年。对患有和未患有糖尿病的肝硬化患者,以及进一步细分为既往糖尿病和肝源性糖尿病的患者,研究其各种并发症及包括死亡在内的结局。采用卡方检验和曼-惠特尼检验比较数据。
肝硬化合并糖尿病的患者胆结石发生率较高(27.6%对13.2%;p = 0.008),尿路感染发生率也较高(29.3%对7.5%;p < 0.001)。两组之间肝细胞癌发生率和死亡率相似。既往糖尿病患者和肝源性糖尿病患者在并发症和死亡率方面相似。Child-Turcotte-Pugh(CTP)评分、终末期肝病模型(MELD)评分、尿路感染和呼吸道感染以及肝硬化病程是肝硬化患者死亡率的独立预测因素。
糖尿病并存会增加肝硬化患者的并发症发生率和住院率,但对死亡率无影响。既往有糖尿病的肝硬化患者和肝源性糖尿病患者在发病率和死亡率方面无显著差异。